Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
2 Bear Market Stocks That Can Make You Richer in 2022 and Beyond
01:15pm, Friday, 09'th Dec 2022 The Motley Fool
A bear market can present fresh opportunities for long-term investors.
Get ready for a 'confusing' respiratory illness season
12:14pm, Friday, 09'th Dec 2022 MarketWatch
There are currently higher-than-normal levels of RSV and the flu in the U.S. At the same time, the number of new COVID-19 infections is rising.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:32am, Friday, 09'th Dec 2022
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
03:01am, Friday, 09'th Dec 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
ETF Investing Strategies for 2023
09:10pm, Thursday, 08'th Dec 2022 Zacks Investment Research
We discuss the market outlook and investing strategies for 2023.
Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims
06:28pm, Thursday, 08'th Dec 2022 Benzinga
HC Wainwright initiated coverage on Gracell Biotechnologies Inc (NASDAQ: GRCL) with a Buy rating and a price target of $6.
The China-based company is focused on developing autologous and allogenei
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
03:15pm, Thursday, 08'th Dec 2022 The Motley Fool
The three companies are changing the pharmaceutical industry.
This Monster Dividend Stock Isn't Done Growing
02:00pm, Thursday, 08'th Dec 2022 The Motley Fool
Is another deal on the way for Johnson & Johnson?
3 Hot Stocks That Could Live Up to Their Lofty Valuations
11:45am, Thursday, 08'th Dec 2022 The Motley Fool
These companies have long runways of growth ahead
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
10:15am, Thursday, 08'th Dec 2022
The three companies are changing the pharmaceutical industry.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
11:20am, Wednesday, 07'th Dec 2022 Zacks Investment Research
Smart Beta ETF report for VIG
Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know
10:45pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Johnson & Johnson (JNJ) closed the most recent trading day at $176.10, moving -1.5% from the previous trading session.
Johnson & Johnson: Reducing Corporate Risk And Increasing Growth
02:47pm, Tuesday, 06'th Dec 2022
Johnson & Johnson announced that it will acquire Abiomed for $380 per share in cash, and will close before the end of the first quarter of 2023. With Abiomed's gross margins of 82%, higher than Johnso
Johnson & Johnson: Alzheimer's Disease Pipeline Could Dominate
04:56pm, Monday, 05'th Dec 2022
Johnson & Johnson selected a vaccine to take to Phase 3. Another rival amyloid beta antibody could appear on the market next year.
7 Iron-Clad Stocks That Will Resist the Market Turmoil
03:22pm, Monday, 05'th Dec 2022
The concept of targeting iron-clad stocks to buy for volatility might seem overkill. After all, the Labor Department just revealed that the U.S. economy added 263,000 jobs, above analysts' expectation
